Letter: Bleeding in Cirrhotics Receiving Coronary Stenting and Antiplatelet Therapy

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14244
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Dual Antiplatelet Therapy After Stenting in All-Comers, ACS Patients and in High Bleeding Risk

English

Dual Antiplatelet Therapy Duration After Coronary Stenting in Clinical Practice: Results of an EAPCI Survey

EuroIntervention
MedicineCardiovascular MedicineCardiology
2015English

Antiplatelet Therapy in Acute Coronary Syndrome

Continuing Cardiology Education
2017English

Letter: The Treatment of Coronary Artery Disease in Cirrhotics Needs More Thinking

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Efficacy and Safety of Triple Therapy Versus Dual Antiplatelet Therapy in Patients With Atrial Fibrillation Undergoing Coronary Stenting: A Meta-Analysis

PLoS ONE
Multidisciplinary
2018English

Letter: The Treatment of Coronary Artery Disease in Cirrhotics Needs More Thinking-Author's Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

CAR 6. Dual Antiplatelet Therapy and Clopidogrel “Resistance” in Carotid Stenting: Preliminary Results

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2018English

Cardiovascular and Bleeding Risk of Non-Cardiac Surgery in Patients on Antiplatelet Therapy

Journal of Cardiology
Cardiovascular MedicineCardiology
2014English

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy